Microbiological profile of ventilator-associated pneumonia among intensive care unit patients in tertiary Egyptian

Alaa M Farag1, Mahmoud M Tawfick2, Mostafa Y Abozeed3

  • 1Microbiology and Immunology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt. alaa244342@hotmail.com.

Abstract

Insights

Ventilator-associated pneumonia (VAP) in ICUs is often caused by multidrug-resistant Gram-negative bacteria like Klebsiella spp. This study found no common infection source, suggesting endogenous origins for K. pneumoniae.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a significant ICU infection with severe consequences.
  • Antimicrobial resistance and non-specific symptoms complicate VAP diagnosis and treatment.
  • Understanding the microbial landscape of VAP is crucial for effective management.

Purpose of the Study:

  • To identify VAP-causing microbes in Egyptian ICUs.
  • To analyze antimicrobial susceptibility patterns.
  • To assess genetic diversity among common VAP pathogens.

Main Methods:

  • Endotracheal aspirates from suspected VAP cases were collected over one year.
  • Microbial identification and antimicrobial susceptibility testing (Kirby-Bauer method) were performed.
  • Genotyping of frequently isolated organisms was done using ERIC-PCR.

Main Results:

  • Fifty VAP cases were confirmed, predominantly caused by Klebsiella spp., Pseudomonas aeruginosa, and Acinetobacter baumannii.
  • Candida spp. were the most common fungi; rare isolates included Cupriavidus pauculus and Aeromonas salmonicida.
  • Forty percent of isolates exhibited multidrug resistance (MDR).
  • No genetic links were found among Klebsiella pneumoniae isolates.

Conclusions:

  • Gram-negative bacteria, often multidrug-resistant, are primary VAP agents.
  • Cupriavidus pauculus and Aeromonas salmonicida warrant consideration as VAP pathogens.
  • The lack of common source suggests endogenous K. pneumoniae infections in this ICU cohort.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...